SCHEMBL7223307

SCHEMBL7223307

CCCOc1cccc(Oc2ccc3c(c2)C=C(C(=O)Nc2ccc(CN(C)C4CCOCC4)cc2)CCS3(=O)=O)c1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 4/20 0.48
CCR5 P51681 3/20 0.44
LTA4H P09960 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
THRB P10828 1/20 0.35
LMNA P02545 1/20 0.34
MEN1 O00255 1/20 0.34
ADRB2 P07550 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
CXCR5 P32302 1/20 0.34
CXCR3 P49682 1/20 0.34
FABP1 P07148 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221572 0.95 CCR2 (0.49) CCR2CCR5LTA4HL3MBTL1NPC1
SCHEMBL7167251 0.94 CCR2 (0.47) CCR2CCR5LTA4HL3MBTL1NPC1
SCHEMBL7218125 0.93 CCR2 (0.47) CCR2CCR5LTA4HL3MBTL1NPC1
SCHEMBL7218003 0.93 CCR2 (0.46) CCR2CCR5L3MBTL1NPC1RAB9A
SCHEMBL7218136 0.92 CCR2 (0.49) CCR2CCR5L3MBTL1NPC1RAB9A
SCHEMBL7971833 0.92 CCR2 (0.55) CCR2CCR5CXCR5CXCR3
SCHEMBL7165818 0.92 CCR2 (0.49) CCR2CCR5L3MBTL1NPC1RAB9A
SCHEMBL7216597 0.91 CCR2 (0.48) CCR2CCR5L3MBTL1NPC1RAB9A
SCHEMBL3031528 0.90 CCR2 (0.58) CCR2CCR5L3MBTL1CXCR5CXCR3
SCHEMBL30227218 0.90 CCR2 (0.58) CCR2CCR5L3MBTL1CXCR5CXCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed